Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

NCT04977076 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.

NCT NCT04977076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04977076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention
Lead sponsor
Zuyderland Medisch Centrum
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2022
Completion date
December 31, 2027
Enrollment
1,270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants, atrial fibrillation, coronary artery disease